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1. Introduction
Drug delivery is the method or process of administering a pharmaceutical compound to
achieve a therapeutic effect in humans or animals. Most common routes of administration
include the preferred non-invasive peroral (through the mouth), topical (skin), transmucosal
(nasal, buccal/sublingual, vaginal, ocular and rectal) and inhalation routes. Many
medications such as peptide, antibody, vaccine and gene based drugs, in general may not
be delivered using these routes because they might be susceptible to enzymatic degradation
or cannot be absorbed into the systemic circulation efficiently due to molecular size, to be
therapeutically effective. For this reason such drugs have to be delivered by injection. For
example, many immunizations are based on the delivery of protein drugs and are often done
by injection. Current effort in the area of drug delivery include the development of targeted
delivery in which the drug is only active in the target area of the body (for example, in
cancerous tissues) and sustained release formulations in which the drug is released over a
period of time in a controlled manner from a formulation Cemazˆar et al. (1998); Sersˆa (2000);
Sersˆa et al. (1993). This is achieved by combining phenomenon of electroporation with the
application of drugs.
This makes the area of drug delivery a study in which experts from most scientific discipline
can make a significant contribution. To understand the barriers to drug delivery, it is
useful to consider anatomical structures at a length scale suitable for variety of structures:
a cell, a tissue, a muscle, organ. Better medical treatments may not always require stronger
medicinal drugs. A better effect could be achieved by an effective method of administration.
Often differences in the mode of drug administration produce substantial changes in drug
concentration requirement, and thus can affect the unnecessary side effects of some of the
drugs in favor of the patient. A good example of this is electrochemotherapy. The major
disadvantage of clinically established chemotherapeutic drugs is their lack of selectivity of
tumor cells. Therefore for a noticeable antitumor effect, high doses of the chemotherapeutic
drugs are needed, which often cause systemic toxicity leading to severe side effects Sersˆa et al.
(1993). In cancer chemotherapy, some drugs do not exhibit anti-tumour effects because of
impeded transport through the cell membrane Miklavcˆicˆ and Kotnik (2004). To overcome this
difficulty, a number of new approaches for drug delivery systems have been attempted. One
of the approaches to better drug delivery is by making it topical and more effective at the
tumor site with the use of electric field . This is electrochemotherapy. In this article a brief
overview of electroporation and its use in electrotherapy is discussed.
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2. Electrochemotherapy (ECT)
The combined use of chemotherapeutic drugs alongwith electroporation caused due to
application of electric pulses is known as electrochemotherapy and is useful for local tumour
control. Bleomycin and cisplatin which are commonly used drugs for chemotherapy have
proven to be much more effective in electrochemotherapy than in standard chemotherapy
when applied to tumour cell lines in vitro, as well as in vivo on tumours in mice Mir et al.
(1991; 1995); Sersˆa et al. (1995). Clinical trials have been carried out with encouraging results
Glass et al. (1996); Gothelf et al. (2003); Kranjc et al. (2005); Sersˆa et al. (2000); Snoj et al. (2005);
Tozon et al. (2005). Especially, bleomycin has been reported to have shown a 700-fold increased
cytotoxicity when used in ECT Cemazˆar et al. (1998); Sersˆa (2000).This helps to achieve a
substantial anti-tumour effect with a small amount of drug, that limits its side effects Sersˆa
et al. (1993).
2.1 Electroporation
It is possible to induce the formation of hole in a cell membrane by applying a sufficiently
strong electric field pulse. This is known as electroporation. The effect is reversible when
the cell membrane is temporarily permeated. Irreversible electroporation occurs when the
cell membrane poration is of such a nature as to induce cell death. Polarization is one of the
basic mechanisms of interactions of membranes with electric fields, leading to electroporation
and related phenomenons of dielectrophoresis Neumann (1989); Pohl (1978) and electrofusion
Neumann (1989); Zimmermann (1982).
2.1.1 Polarization of membranes
Polarization of membranes underlies their destabilization. Polarization is due to restricted
motion of charges: electric fields exert forces on charges. These charges can either move if
they are free (material is conductive) or accumulate if they are limited in their movement.
This charge redistribution in a particular limited space leads to polarization. Figure 1 shows
polarization of a single cell due to restriction by the cell membrane to the motion of ions.
2.2 Electric field interaction with polarized membranes and pore formation
The interaction of external electric field with the polarized membranes results in forces which
can induce motions inside particles. This motion can result in structural rearrangement
or fracture in the material. This can subsequently lead to electroporation and related
phenomenon in case of cell membranes Dimitrov (1995); Pohl (1978). Membranes have low
polarizability (relative dielectric constant about 5) and low conductivity (3×10−7 S/m) Kotnik
et al. (1998). The cell membrane is generally bounded (externally and internally) by a medium
of high dielectric constant (about 80) and a high conductivity (about 1.2 S/m). Application
of external fields leads to accumulation of charge at the membrane surfaces; this creates an
electric field inside the membrane that is much stronger than the surrounding field. The
polarized membrane interacts with this field, resulting in structural rearrangements which
can cause membrane poration.
It soon became apparent that a field-induced permeability increase is transient in nature
although long-lived compared with the field duration. The term ‘electropermeabilization’
was used to explain the occurrence of permeability changes introduced by electrical impulses
in vesicular membranes Neumann and Rosenheck (1972). It was later shown that the electric
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Fig. 1. Spherical particle in electric field, E is the electric field (Adapted from Chang et al.
(1992); Dimitrov (1995)).
field induced change was transient Rosenheck et al. (1975) . The resistance changes in the
membrane were attributed to dielectric breakdown Zimmermann et al. (1973).
Subsequent studies showed that the cell membranes of pulse treated cells were permeable to
molecules of a size smaller than a certain limit, suggesting the creation of a porous membrane
structure Kinosita and Tsong (1977b); Neumann and Rosenheck (1972); Zimmermann et al.
(1973). It was also found that under appropriate conditions, the cells could recover, which
implied that these electropores were resealable and could be induced without permanent
damage to the cell Zimmermann et al. (1980), and the cytoplasmic macromolecular contents
could be retained Kinosita and Tsong (1977a;b). Since then, a number of research groups
have studiedmechanisms of pore formation and detailed characteristics of the cell membranes
modified by electric fields Abidor et al. (1979); Chernomordik et al. (1983); Glaser et al. (1988);
Schwister and Deuticke (1985).
However, the pores themselves were not observed until the invention of rapid freezing
electron microscopy in the 1990s. Chang et.al Chang and Reese (1990) were the first to observe
them. Other aspects of electroporation, for example, vizualization of transmembrane potential
and its evolution in space and time, resealing of pores and asymmetry in permeability of
porated cells (sea urchin egg and liposomes) with the help of an optical microscope, were also
reported Hibino et al. (1993); Kinosita et al. (1992). These microscopes have a time resolution
of sub-microseconds suitable for studying electroporation.
2.2.1 Types of pores
The pores are assumed to be hydrophobic or hydrophilic. The hydrophobic pores, as shown
in Figure 2a Abidor et al. (1979); Glaser et al. (1988); Neu and Krassowska (1999), are simply
gaps in the lipid bilayer of the membrane, formed as a result of thermal fluctuations.
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Fig. 2. Types of electropores: (a) Hydrophobic (nonconduting pore), (b) Hydrophilic pore
(conducting pore).
The primary pores that participate in electrical behaviour andmolecular transport are thought
to be hydrophilic pores, with aminimum radius of about 1 nm, and a reasonable probability of
various pore sizes much larger Weaver (1993). The ‘hydrophilic’ or ‘inverted pores,’ as shown
in Figure 2b, have their walls lined with the water-attracting heads of lipid molecules. Hence,
the hydrophilic pores allow the passage of water-soluble substances, such as ions, while the
hydrophobic pores do not.
2.3 Facts about electrochemotherapy
Due to the availability of these electropores, electroporation can and has been used to deliver
a variety of molecules for the purpose of DNA transfer, anesthesia, cosmetics, vaccination and
chemotherapy. We discuss the electrochemotherapy details and results in brief as below.
1. Many studies reported that with belomycin doses far below toxicity, antitumour
effectiveness of electrochemotherapy induced good responses of the tumours including
tumour cures Sersˆa (2000).
2. It has also been found that some tumours are more sensintive to one drug than to another
used in electrochemotherapy Sersˆa (2000).
3. Not all tumours have equal level of sensitivity to electrochemotherapy with bleomycin,
but all tumor types (e,g., breast, colon, bladder, renal cell, malignant melanoma, basal cell
carcinoma) have shown a response to electrochemotherapy Gehl (2008); Sersˆa (2000).
4. Electrochemotherapy with bleomycin was performed on tumours in internal organs
(brains and livers in rats) Sersˆa (2000).
5. Complete eradication of treated nodules occurs in approximately 75% of the cases, and at
least a partial remission occurs in 85-90% of the treated patients Gehl (2008).).
6. Mostly square pulses of duration 100 us, with electric field intensity of 1300V/cm or
1500V/cm, repetition frequency of 1 Hz is used. With higher amplitudes more cells in
the tumour are permeabilized Gehl (2008).
7. Permeabilization of tumour cells is also dependent on the number of electric pulses, with
eight electric pulses found optimum Jaroszeski et al. (2000).
8. Antitumour effectivenss is dependent on drug concentration in the tumour during
application of electric pulses, a 3-minute interval between the treatments is optimal
Jaroszeski et al. (2000).
9. The second most useful drug for electrotherapy has been found to be cisplatin. This is
one of the drugs that induces resistance in cells, often early in the course of chemotherapy
treatments. Electroporation has demonstrated itself to overcome this resistance of cells to
cisplatin, at least to some degree Sersˆa (2000).
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10. Other attempts to determine whether other drugs would be effective in
electrochemotherapy protocol in vivo do not prove to be good candidates because
of their lipophilicity (being soluble in fat solvents) Sersˆa (2000).
11. Achieving optimal electroporation during therapy without the need for repetitive
treatment is an issue yet, however several ways of obtaining this are under research e.g.
optimization of electric field by proper choice of value, number and duration of pulses
and type of electric field, needle electrode design, rotating these needles between pulses
Jaroszeski et al. (2000); Sersˆa et al. (1993).
12. Impact of electrochemotherapy on the formation of metastates is yet to be established
with preclinical and clinical studies, however studies have shown decreased number of
metastases in rats Orlowski et al. (1998).
2.4 Noteworthy treatments of electroporation
There are many other special noteworthy applications of electrochemotherapy/
electroporation worth mentioning separately as below:
1. Treatment of human pancreatic tumours: cancers of pancreas is currently the fifth leading
cause of cancer related deaths with a very low five year survival in the United States
Jaroszeski et al. (2000). Since it is hard to detect in the early stages, it becomes difficult
to treat. Conventional chemotherapeutic agents have not been vey effective for human
pancreatic cancers Talele et al. (1991). A novel cancer treatment that uses a single
intratumoral injection of bleomycin followed by application of the tumour site with square
wave pulses has produced a large percentage of cures and a good number of partial
regression in many different forms of cancers e.g. in human larynx Nanda et al. (1998b),
human pancreas Dev et al. (1997); Nanda et al. (1998a).
2. Electrofusion (EF): Under appropriate physical conditions, delivery of electric pulses can
lead to membrane fusion in close-contact adjacent cells. EF results in the encapsulation
of both original cellsíntracellular material within a single enclosed membrane and can be
used to produce genetic hybrids or hybridomas Zimmermann (1982). Hybridomas are
hybrid cells produced by the fusion of an antibody secreting stimulated B-lymphocytes,
with a tumour cell that grows well in culture. The hybridoma is then able to continue to
grow in culture, and a large amount of specific desired antibodies can be recovered after
processing. Electrofusion has proved to be a successful approach in the production of
vaccines Orentas et al. (2001); Scott-Taylor et al. (2000), antibodies Schmidt et al. (2001), and
reconstructed embryos in mammalian cloning Gaynor et al. (2005).
3. Transdermal drug delivery (TDD): Application of high-voltage pulses to the skin allows
a large increase in induced ionic and molecular transport across the skin barrier
Prausnitz et al. (1993). This has been applied for transdermal delivery of drugs, such as
metoprolol Vanbever et al. (1994), and also works for larger molecules, for example, DNA
oligonucleotides Vanbever et al. (1994).
4. Electroinsertion (EI): Another application of electroporation is insertion of molecules into
the cell membrane. As the electric field induced membrane pores reseal, they entrap some
of the transported molecules. Experiments on electroinsertion suggest the possibility of
using the process to study certain physiological properties of these cells and understanding
aspects of the lipid-protein interactions of the cell plasma membrane Mouneimne et al.
(1992).
103herapeutic Applicati ns of Electroporation
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2.5 Known side effects of electrochemotherapy
1. During electrochemotherapy, the pulse delivery is usually painful for patients due to a a
muscle contraction. Generally, a number of electric pulses are delivered, with a repetition
frequncy of 1 Hz, which results in equal number of individual sensations and muscle
contractions Zupanic et al. (2007). To reduce the number of individual muscle conractions,
use of pulse frequncy larger than the frequncy of tetanic contraction has been suggested
Miklavcic et al. (2005). It has been reported that increasing the pulse repetition frequncy to
5 kHz lowers the number of contractions, whereas clinical effectiveness remains same as
that achieved by 1 Hz Marty et al. (2006); Snoj et al. (2007).
2. Just after the electric pulse delivery to the tumour nodule on the mice flanks, it is regularly
observed a transient paralysis of the hind legs of the treated mouse, which lasts less than
one minute and is always totally reversible Orlowski and Mir (2000).
3. Few days after electrochemotherapy, small scabs are often observed on the skin just at the
level of electrode application. They always heal after a few days Orlowski and Mir (2000).
4. The delivery of electric pulses to tumours induces changes (reduced) in tumour blood flow.
These changes have been observed to be sensitive to the frequency of applied electric field.
The immediate reduction in tumour blood flow at 5 kHz was higher than the reduction
at 1 Hz during the initial perid following pulse delivery however at longer times, the 5
kHz frequency had effects on tumour bood flow comparable to those abserved at 1 Hz
Raeisi et al. (2010). Reduction in tumour blood flow may result in trapping of the drug in
tumours, thus providing a longer time for the drug to act by decrease the drug washout
from the tumour Mir (2006).
5. That antitumour effectiveness of electrochemotherapy is not only due to increased
cytotoxicity of the drugs due to electroporation of tumour cells, but also due to reduced
tumour blood flow and oxygenation Sersa et al. (2008).
3. Electrogenetherapy
Application of electroporation for transfer of DNA into cells to effect some form of gene
therapy, often referred to as electrogenetransfection/electrogenetherapy, is currently being
applied in some clinical trials. It is presently considered to have large potential as a non-viral
method to deliver genetic material into cells, the process aimed at correcting genetic diseases
Budak-Alpdogan et al. (2005). The genes being coiled up need a larger electropore for a longer
time in order for it to enter the cells. Numerical modelling is useful to establish appropriate
parameters to achieve this Krassowska and Filev (2007); Talele and Gaynor (2007); Talele
et al. (2010). We have seen that due to electroporation the cells can be permeabilized such
that the barrier function of the membrane is instantaneously compromised. During this
time, genetic material may travel across the membrane. A successful gene transfer process
is the one where the electrical and biological conditions of the cell are such that the barrier
function of the cell membrane is rapidly restored for a cell survival. This process is termed
a electrogenetransfer and when used for therapeutic purpose, electrogenetherapy. For gene
therapy to be successful, the gene must be transferred efficiently to target cell without the cell
damaging side effects. Most common method for gene transfer in the literature is the viral
vector method to attach the gene of interest to enter in the target cell. This method may have
detrimental effects of the virus Feuerbach and Crystal (1996) and thus alternative methods of
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gene transfer are necessary. The electrogenetherapy seems to be the most promising one since
the side effects are close to none.
One very obvious fact is that the intake of genetic material by an electroporated cell is
affected by the extent of cell membrane permeabilization. This can be dependent on several
parameters like cell diameter, cell membrane thickness and capacitance, internal and external
conductivities, the electric pulse parameters used for electroporating, the time duration they
are used for and so on. Many of these parameters have an interdependent and a non
linear effect on the end result and need complex mathematical use to be explained in full
details. Without getting into these details, I would like to mention some prominent simple to
understand comments about electrogenetherapy.
1. Once the cell is permeabilized by a pulse, more DNA enters the cells during the next pulse
of lower field strength Sukharev et al. (1992). Multiple pulses and AC pulses seem to have
better results Chang et al. (1991).
2. Adding the DNA immediately after the pulse usually results in a much lower transfection
efficiency compared to adding DNA before the pulse Andreason and Evans (1989).
3. For a given pore forming pulse electric field, the transfection efficiency depends more
on the total length of the pulses than of the time span when cells remain permeable,
which suggests that uptake of DNA adsorbed on cell surfaces would also contribute to
this efficiency Nickoloff and Reynolds (1992).
4. Other physical parameters such as geometry and concentration of DNA are also important
e.g. bigger size DNA would need bigger pores on the cell wall and thus would be hard to
enter Nickoloff and Reynolds (1992).
5. The transfection efficiency decreases with increasing gap between repeating pulses Chang
et al. (1991). This also suggests that DNA is collected on the cell surface for subsequent
push through the electropores.
6. If the electro pores are too large that cell membrane is unable to reseal then the cell dies.
7. Another reason the cells may not survive is the osmotic swelling. This is due to selective
permeability of the membrane after electroporation. Once electroporated, the intracellular
cell material molecules being large, these molecules cannot escape outside, however the
small ions from outside can enter in, causing the cell to swell leading to bursting and death
Baker and Knight (1983).
4. Conclusion
Electroporation may be widely used as a cancer treatment in near future with advantages of
low toxicity and being topical and more effective at the tumor site. Newer drugs suitable
for various types of cancers and an optimum methodology of application of the electric field
is under extensive research. Electroporation may also be the popular phenomenon used for
genetherapy without use of viral vectors.
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